Fidelity Investments
EDSA icon

Fidelity Investments’s Edesa Biotech EDSA Stock Holding History

Fidelity Investments’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-142
Closed -$589 – 5434
2024
Q1 		$589 Buy
+142
New +$661 ﹤0.01% 4834
2022
Q3 		– Sell
-43
Closed – – 4977
2022
Q2 		$0 Buy
+43
New +$634 ﹤0.01% 5032

Other funds holding EDSA

CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments's EDSA Position: Q2 2024 in Review

Fidelity Investments sold out of Edesa Biotech (EDSA) in Q2 2024, closing a stake of 142 shares — an estimated $589 sold.

Fidelity Investments first reported a position in EDSA in Q2 2022 and held it in 2 quarters. The position peaked at $589 in Q1 2024. 17 funds tracked by Wall St. Rank hold EDSA as of Q2 2024.

  • Fidelity Investments reported no remaining Edesa Biotech position as of Q2 2024 after selling out during the quarter.
  • Fidelity Investments sold 142 Edesa Biotech shares in Q2 2024, an estimated $589.
  • Fidelity Investments first reported a position in Edesa Biotech in Q2 2022 and held it in 2 quarters.
  • Fidelity Investments's Edesa Biotech position peaked at $589 in Q1 2024.
  • 17 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2024.

Based on Fidelity Investments's 13F filing for Q2 2024, filed 13 Aug 2024.